
Polarized-light imaging shows potential for distinguishing Ehlers–Danlos subtypes
In a recent study by researchers in Toronto (Canada), scientists tested an optical method called Mueller matrix polarimetry to address a diagnostic gap.

In a recent study by researchers in Toronto (Canada), scientists tested an optical method called Mueller matrix polarimetry to address a diagnostic gap.

Engineers at Stanford University have developed a high-efficiency, battery/solar-operated, autonomous microscope with integrated artificial intelligence that automatically diagnoses malaria in blood smears

Research on their new robotic crash cart (RCC)—a robotic version of the mobile drawer unit that holds supplies and equipment needed for a range of medical procedures.

Researchers at Houston Methodist Research Institute have now discovered a promising new approach that can protect patients from radiation-induced skin damage during cancer treatment.

In the future, more targeted strategies that dampen damaging, chronic oxidative stress while preserving—or even harnessing—these short-lived pro-healing signals could open new avenues to promote brain repair.

Artificial intelligence could help doctors detect serious heart valve disease years earlier, potentially saving thousands of lives, a new study suggests.

University of Missouri researchers are developing new ways to better simulate the complex nature of human brain tissue.

Stimulating two brain areas, nudging them to collectively fire in the same way, increases a person’s ability to behave altruistically.

Scientists at the University of Maryland have created Smart Underwear, the first wearable device designed to measure human flatulence.

ANDOVER, Mass., Feb. 9, 2026 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug Administration (FDA) has granted full approval of its Investigational Device Exemption (IDE) for the Next-Generation OCS ENHANCE Heart trial.